HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of prenylcysteines that interact with P-glycoprotein and inhibit drug transport in tumor cells.

Abstract
Prenylcysteine methyl esters that represent the C-terminal structures of prenylated proteins demonstrate specific substrate-like interactions with P-glycoprotein (Zhang, L., Sachs, C. W., Fine, R. L., and Casey, P. J. (1994) J. Biol. Chem. 269, 15973-15976). The simplicity of these compounds provides a unique system for probing the structural specificity of P-glycoprotein substrates. We have further assessed the structural elements of prenylcysteines involved in the interaction with P-glycoprotein. Carboxyl group methylation, a modification in many prenylated proteins, plays an essential role of blocking the negative charge at the free carboxylate. Substitution of the methyl ester with a methyl amide or simple amide does not change the ability of the molecule to stimulate P-glycoprotein ATPase activity, but substitution with a glycine is not tolerated unless the carboxyl group of glycine is methylated. The presence of a nitrogen atom, which is found in many P-glycoprotein substrates and modifiers, is also essential for prenylcysteines to interact with P-glycoprotein. The structure at the nitrogen atom can, however, influence the type of interaction. Acetylation of the free amino group of prenylcysteine/results in a significant loss in the ability of prenylcysteines to stimulate P-glycoprotein ATPase activity. Instead, certain acetylated prenylcysteines behave as inhibitors of this activity. In studies using MDR1-transfected human breast cancer cells, the acetylated prenylcysteine analogs inhibit P-glycoprotein-mediated drug transport and enhance the steady-state accumulation of [3H]vinblastine, [3H]colchicine, and [3H]taxol. These inhibitors do not, however, affect drug accumulation in parental cells. These studies provide a novel approach for designing P-glycoprotein inhibitors that could prove effective in reversing the phenotype of multidrug resistance in tumor cells.
AuthorsL Zhang, C W Sachs, H W Fu, R L Fine, P J Casey
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 270 Issue 39 Pg. 22859-65 (Sep 29 1995) ISSN: 0021-9258 [Print] United States
PMID7559420 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Recombinant Proteins
  • Adenosine Triphosphatases
  • Cysteine
Topics
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 (biosynthesis, metabolism)
  • Adenosine Triphosphatases (metabolism)
  • Animals
  • Biological Transport (drug effects)
  • Breast Neoplasms
  • Cell Line
  • Cell Membrane (metabolism)
  • Cysteine (analogs & derivatives, pharmacology)
  • Drug Resistance, Multiple (genetics)
  • Female
  • Humans
  • Kinetics
  • Recombinant Proteins (biosynthesis, metabolism)
  • Spodoptera
  • Structure-Activity Relationship
  • Transfection
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: